SEMA3A and Hypoglycemia: Our data demonstrate that soluble sNRP1, VEGF or SEMA3A and ADAM9 levels did not differ from control subjects in the basal condition in obese T2D; however, an alteration of their levels was observed in response to insulin-induced hypoglycemia.